Safety Study of Using Symlin Alongside Insulin in a Multiple Injection Port
Clinical trial NCT00790699 · TERMINATED
Trial details
- NCT number
- NCT00790699
- Sponsor
- Texas Diabetes & Endocrinology, P.A.
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-01
- Primary completion
- 2011-11-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.